| Patient | Robert Peary |
|---|---|
| Date of birth | 1963-05-06 |
| Identifiers | MRN HR-EX004-SYN; SSN (made up) 000-04-7351 |
| Document date | 2026-04-28 |
| Author | Thaddeus Lindgren-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Fifteen-week review: neurological recovery, iron and lifelong maintenance. [S]
Admiral Peary returns fifteen weeks after starting treatment. He walks two miles a day with his stick, mostly for safety on rough ground, and has had no falls. The numbness at the ends of his feet is less but has changed little over the past month. He has taken the iron every other day without stomach upset and has given himself every weekly injection. His feet have stayed whole, and podiatry has booked his next visit. He is writing again for several hours a day. His HIV, hepatitis C and hepatitis B tests from the preventive visit were negative, and he was told by phone. He asked whether he could take tablets instead of injections. [S]
| Element | Detail |
|---|---|
| Hemoglobin | 14.8 g/dL; MCV 90 fL |
| Iron | Ferritin 64 ng/mL; saturation 27% |
| Nerves | Romberg negative; vibration reduced at the ankles; numbness at the ends of the feet, little change in a month |
| Mood and cognition | PHQ-9 2; MoCA 28 |
| Screening results | HIV, hepatitis C and hepatitis B negative |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy normal |
| Gastrointestinal | Negative | No indigestion, constipation or black stools on iron |
| Neurological | Positive | Numbness at the ends of the feet; balance much better |
| Psychiatric | Negative | Mood good; PHQ-9 2 |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection every other day for seven doses, given by the clinic nurse after the intake blood tests were drawn | 1,000 micrograms into the muscle every other day, seven doses | Intramuscular route | 2026-01-13 to 2026-01-25 | completed | S |
| Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a week while the nerves recover | 1,000 micrograms into the muscle once a week, self-injected after teaching | Intramuscular route | 2026-02-01 to 2026-04-26 | completed | S |
| Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a month for life | 1,000 micrograms into the muscle every four weeks, self-injected, for life | Intramuscular route | 2026-04-28 | active | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet every other day on an empty stomach with a glass of orange juice | One tablet every other day, apart from tea and coffee, for three months after the ferritin is normal | Oral route | 2026-03-10 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-28 | Body height | 183 | cm | S |
| 2026-04-28 | Body weight | 74.6 | kg | S |
| 2026-04-28 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 2026-04-28 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-04-28 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-04-28 | Heart rate | 70 | /min | S |
| 2026-04-28 | Respiratory rate | 14 | /min | S |
| 2026-04-28 | Body temperature | 36.6 | Cel | S |
| 2026-04-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-28 | Hemoglobin [Mass/volume] in Blood | 14.8 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-04-28 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 90 | fL | 80-100 fL | Normal | S |
| 2026-04-28 | Erythrocyte [DistWidth] in Blood by Automated count | 13.8 | % | 11-15% | Normal | S |
| 2026-04-28 | Ferritin [Mass/volume] in Serum or Plasma | 64 | ng/mL | 30-400 ng/mL | Normal | S |
| 2026-04-28 | Iron saturation [Mass Fraction] in Serum or Plasma | 27 | % | 20-50% | Normal | S |
| 2026-04-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 2026-04-28 | Total score [MoCA] | 28 | {score} | S |
Vital signs recorded on 2026-04-28; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 128/76, pulse 70 |
| Neurological | Vibration reduced but present at the ankles; joint position sense normal; ankle jerks absent; Romberg negative; Timed Up and Go 10 seconds; MoCA 28 |
| Feet | Skin intact; callus small; monofilament felt at 7 of 10 sites on each forefoot |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Fatigue, breathlessness on exertion, pallor with a lemon-yellow tinge, a sore tongue, and numbness and unsteadiness in the feet over about four months, with a macrocytic anemia, low white cells and platelets, a low vitamin B12 and a high methylmalonic acid; cause under evaluation with a hematology consultation | resolved | confirmed | D51.9 | S — Synthetic presenting problem anchored to the documented pernicious anemia of his last years; superseded when the consultation confirmed pernicious anemia. |
| Pernicious anemia (autoimmune gastritis with intrinsic factor antibodies), with severe vitamin B12 deficiency; synthetic modern diagnosis linked to the documented cause of his death | active | confirmed | D51.0 | S — Synthetic modern diagnosis made at the consultation, anchored to his documented death from pernicious anemia; the timing and course in the modern episode are synthetic. |
| Subacute combined degeneration of the spinal cord with peripheral neuropathy from vitamin B12 deficiency: loss of vibration and joint position sense in the feet, absent ankle jerks, brisk knee jerks and a positive Romberg test | active | confirmed | G32.0 | S — Synthetic neurological complication; not a claim about his real nerves. |
| Absence of the second to fifth toes of the right foot after frostbite and amputation in early middle age; healed stumps; callus under the first metatarsal head | active | confirmed | Z89.421 | S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007). |
| Absence of the second to fifth toes of the left foot after frostbite and amputation in early middle age; healed stumps | active | confirmed | Z89.422 | S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007). |
| One fall in a dark bedroom a month ago without injury; unsteady in the dark and on uneven ground; uses a stick outdoors | active | confirmed | Z91.81 | S — Synthetic fall linked to the neuropathy and the old toe amputations. |
| Autoimmune atrophic gastritis, corpus-predominant, with intestinal metaplasia and enterochromaffin-like cell hyperplasia in the body of the stomach, a spared antrum, no Helicobacter pylori, no neuroendocrine tumor and no dysplasia | active | confirmed | K29.40 | S — Synthetic endoscopy and pathology result, the cause of the pernicious anemia; not a claim about his real stomach. |
| Iron deficiency without anemia, unmasked by the recovery of red cell production and the poor iron absorption of atrophic gastritis; colonoscopy and endoscopy without a bleeding source | active | confirmed | E61.1 | S — Synthetic finding at eight weeks. |
| Blister on the end of the left forefoot over the old amputation stump, from boots not yet broken in, in a foot with reduced sensation; no infection; healed in two weeks | resolved | confirmed | S90.822A | S — Synthetic acute foot problem; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Symptoms: fatigue, breathlessness, exercise tolerance, sore tongue, numbness | Every visit during active treatment | Completed today | No fatigue or breathlessness; numbness at the ends of the feet |
| Laboratory | Blood count with MCV | In three months, then yearly | Completed today | Hemoglobin 14.8 g/dL, MCV 90 fL, RDW 13.8% |
| Laboratory | Iron studies (ferritin, transferrin saturation) | When the blood count recovers, and about three months into oral iron | Completed today | Ferritin 64 ng/mL and saturation 27% on oral iron |
| Laboratory | Serum vitamin B12 | Not routinely after replacement starts | Not indicated | Not rechecked |
| Medication safety | Injection plan: doses given, self-injection technique, site problems | Every visit | Completed today | Every weekly injection given; monthly maintenance from today |
| Examination | Neurological examination: vibration, joint position, reflexes, Romberg, gait, cognition | At diagnosis and at follow-up visits for six weeks to three months, then until recovery levels off | Completed today | Romberg negative; vibration reduced at the ankles; ankle jerks absent; recovery levelling off |
| Examination | Falls and gait: falls since the last visit, Timed Up and Go, home hazards | Every visit | Completed today | No falls; Timed Up and Go 10 seconds |
| Survey | Mood (PHQ-9) and cognition (MoCA) | At intake and after treatment | Completed today | PHQ-9 2, item 9 scored 0, from 6; MoCA 28, from 27 |
| Examination | Upper endoscopy with Sydney-protocol biopsies for autoimmune gastritis, neuroendocrine tumors and dysplasia | At diagnosis of pernicious anemia; then by individual risk | Up to date | Next endoscopy in three years |
| Self-management | Feet: daily skin checks, footwear, callus and stump skin, monofilament | Every visit | Completed today | Skin intact; daily checks kept; monofilament felt at 7 of 10 sites |
| Referral | Podiatry | Within four weeks of intake, then every three months | Up to date | Next visit booked for next month |
Goal progress:
Guideline basis: Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014); Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024); AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021); CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026); Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update) (2023); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); Depression and Suicide Risk in Adults: Screening (2023)
Follow-up: Monthly self-injection. Blood count, ferritin and saturation in three months. TSH and blood count yearly. Endoscopy in three years. Podiatry every three months. Second zoster dose by the autumn. [S]